Especially when Natera is trading at $22 a share. Our best hope is that we get purchased or merge with another lab. Otherwise we are toast. Start looking.
Natera will soon be down at SQNM level. That is what investors think of NIPT. Every SQNM employee and investor has been begging for a white knight to come in and rescue them from underwater hell for the last 3 years. No chance its cheap today and only getting cheaper. It is a commodity and the price per test keeps going down
Especially when Natera is trading at $22 a share. Our best hope is that we get purchased or merge with another lab. Otherwise we are toast. Start looking.
No moron 3. The investor are onto the SQNM NIPT accounting- fraudulently inflate the number of reimbursed tests, the amount of reimbursement per test, deflate the costs, and hype the stock price. The shorts are all over this pos
